Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.51 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21237722 | 1.00 | PTGS2 (0.55) | PTGS2FFAR1GRIA4CYP1A2CYP2C9 | |
| SCHEMBL5785245 | 0.89 | FFAR1 (0.51) | FFAR1CYP2C19 | |
| SCHEMBL5787675 | 0.89 | FFAR1 (0.51) | FFAR1CYP2C19 | |
| SCHEMBL2005344 | 0.89 | FFAR1 (0.51) | FFAR1CYP2C19 | |
| SCHEMBL7858991 | 0.85 | FFAR1 (0.67) | PTGS2FFAR1GRIA4ADAMTS4 | |
| SCHEMBL21237780 | 0.85 | FFAR1 (0.67) | PTGS2FFAR1GRIA4ADAMTS4 | |
| SCHEMBL11134856 | 0.84 | PTGS2 (0.56) | PTGS2FFAR1GRIA4MEN1KMT2A | |
| SCHEMBL11489425 | 0.82 | PTGS2 (0.55) | PTGS2FFAR1GRIA4ADAMTS4 | |
| Biphenyl SCHEMBL29287557 | 0.81 | MEN1 (0.47) | PTGS2FFAR1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL12883147 | 0.79 | ACHE (0.65) | FFAR1GRIA4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3401308-B1 | CHIRAL COMPOUND, LIQUID CRYSTAL MATERIAL, METHOD FOR FABRICATION THEREOF, AND DISPLAY DEVICE | BOE TECHNOLOGY GROUP CO LTD (CN) | 2020-05-13 | — | — | EP | disclosed |
| US-20190241810-A1 | Chiral compound, liquid crystal material, preparation method thereof, and display device | Hefei Xinsheng Optoelectronics Technology Co., Ltd (CN) | 2019-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241810-A1 | Chiral compound, liquid crystal material, preparation method thereof, and display device | L1CAM, CCNB1, C1R | PTGS2 4577/4885FFAR1 2148/4885GRIA4 1586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.